Recurrent oculogyric crisis and retrocollis after re-exposure with a low dose of olanzapine

Indian Journal of Pharmacology

Volumn 37, Issue 5, 2005, Pages 337-

  Mendhekar, D N ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; LORAZEPAM; OLANZAPINE; PROMETHAZINE; RISPERIDONE; SEROTONIN; SEROTONIN 2A RECEPTOR; TRIHEXYPHENIDYL;

ADOLESCENT; ARTICLE; CASE REPORT; DRUG EFFECT; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG REEXPOSURE; DYSTONIA; ENCEPHALITIS; EXTRAPYRAMIDAL SYMPTOM; EYE DISEASE; FEMALE; HUMAN; LOW DRUG DOSE; NECK; OCULOGYRIC CRISIS; RECEPTOR AFFINITY; RECURRENT DISEASE; RIGIDITY; SIDE EFFECT;

EID: 26444482848     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: 10.4103/0253-7613.16864     Document Type: Article

References (7)

1. Jaffe ME, Simpson Gm. Reduction of tardive dystonia with olanzapine. Am J Psychiatry 1999;156:2016.
2. Gomez JC, The Safety of Olanzapine compared with other anti-psychotic drugs: J Clin Psychiatry 2001;62:828-9.
3. Raja M, Azzoni A. Novel anti-psychotics and acute dystonic reactions. Int J Neuropsychopharmacol 2001;4:393-7.
4. Beasley CM Jr, Tollefson GD, Tran PV, Satterlee W, Sanger T, Hamilton S. Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial. Neuropsycholopharmacol 1996;14:111-23.
5. Martin J, Gomez JC, Garcia-Bernardo E, Cuesta M, Alvarez E, Gurpegui M. Olanzapine in treatment- refractory schizophrenia: Results of an open-label study. The Spanish group for the study of olanzapine in treatment-refractory schizophrenia. J Clin Psychiatry 1997;58:479-83.
6. Bhana N, Foster RH, Onley R, Plosker GL. Olanzapine: An updated review. Drugs 2001;61:111-61.
7. Benjamin S. Oculogyric crisis in movement disorders in neurology and neuropsychiatry. In: Joseph A, Young R, editors. England: Blackwell Science; 1999.